CBD Merchant Account: Who Approves CBD Payment Processing in 2026

CBD sits in the “regulated but legal” band that card networks treat as high-risk. The product is lawful at the federal level when it is hemp-derived and within the legal THC threshold, yet generalist processors exclude it in their acceptable-use policies. That gap is why CBD merchants get approved automatically at signup and then terminated weeks later, and why the right move is a specialist account from day one rather than a generalist account that will be closed again.

This guide is part of our coverage of high-risk merchant accounts. It covers why CBD is classified the way it is, who underwrites it, what approval actually costs, and the compliance documents that decide most applications. Reviewed by Barak Bachar, a working payments operator who has onboarded regulated-but-legal verticals.

CBD classification: why generalists decline it

CBD is a high-risk category for two reasons that have nothing to do with whether your specific business is legitimate. First, the regulatory picture varies by state and changes over time, which acquiring banks price as uncertainty. Second, CBD has historically carried elevated chargeback and return activity, which raises loss exposure for the bank. Generalist processors handle that uncertainty the simplest way available to them, by prohibiting the category outright in their terms.

The practical consequence: Stripe, PayPal, and Square all exclude CBD. An account that processes for a few weeks before a freeze is not a glitch; it is the policy catching up with the signup. You need an acquiring bank that has decided, in advance, to underwrite CBD.

Processors that approve CBD (and what they underwrite)

The providers below are current, real U.S. high-risk specialists that publicly state CBD or broad high-risk acceptance. Positioning reflects each provider’s stated focus and onboarding model. Rates are quoted per merchant on underwriting, so we do not publish fixed numbers; treat any guaranteed-rate claim as a starting position to verify in writing.

The Certificate of Analysis is the document that decides it

For CBD, the single piece of paperwork that moves an application is the Certificate of Analysis. A Certificate of Analysis is a lab report from an accredited testing facility that states the cannabinoid content of your product and confirms the THC level sits within the legal threshold. Underwriters use it to confirm the product they are about to process for is the compliant product you describe, not a higher-THC item that would breach card-network and legal rules.

Beyond the Certificate of Analysis, expect to provide business formation documents, identification, prior processing statements if you have them, product labels, and a website that carries the required disclaimers. The merchants who get approved quickly are the ones who send a complete, compliant package up front rather than answering underwriting questions one at a time over several weeks.

Reserves and rates: what CBD pricing really turns on

CBD accounts are priced as high-risk, so plan for a higher effective rate than standard retail and, in most cases, a rolling reserve. The reserve, not the headline rate, is usually the lever that matters most to your cash flow, and it is negotiable once you have a clean processing history. For how reserves work and how to bring one down in writing, see our explainer on capped vs rolling reserves and frozen funds.

If your business spans more than one regulated vertical, the same underwriting logic applies elsewhere. See our guides to nutra and supplement merchant accounts and firearms merchant accounts for the document sets and processor fit in those categories.

Frequently Asked Questions